Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Becaplermin> ?p ?o }
Showing triples 1 to 73 of
73
with 100 triples per page.
- Becaplermin abstract "Becaplermin (brand name Regranex) is a cicatrizant, available as a topical gel. Regranex is a human platelet-derived growth factor indicated along with good wound care for the treatment of lower extremity diabetic neuropathic ulcers. Use for diabetic foot ulcers has been described. Studies of becaplermin showed that when used with good wound care, complete healing significantly increased and the ulcers healed on average 6 weeks faster. Pharmacoeconomic studies reinforce the cost effectiveness of becaplermin as an adjunct to good wound care.The amount of becaplermin to be applied will vary depending upon the size of the ulcer area. Becaplermin should be stored in the refrigerator. It is also known as \"platelet-derived growth factor BB\". Analysis of healing human wounds showed that PDGF-BB induces fibroblast proliferation and differentiation and was found to increase healing in patients with decreased healing capacity, such as people living with diabetes. Boxed warning has been added to the safety label to describe an increase rate of death from cancer when three or more tubes are used.Regranex should be used with caution in patients with known malignancy.".
- Becaplermin atcPrefix "A01".
- Becaplermin atcSuffix "AD08".
- Becaplermin atcSupplemental ",".
- Becaplermin casNumber "165101-51-9".
- Becaplermin drugbank "DB00102".
- Becaplermin fdaUniiCode "1B56C968OA".
- Becaplermin wikiPageExternalLink www.regranex.com.
- Becaplermin wikiPageID "12745791".
- Becaplermin wikiPageLength "4383".
- Becaplermin wikiPageOutDegree "7".
- Becaplermin wikiPageRevisionID "691417139".
- Becaplermin wikiPageWikiLink Boxed_warning.
- Becaplermin wikiPageWikiLink Cancer.
- Becaplermin wikiPageWikiLink Category:Dermatologic_drugs.
- Becaplermin wikiPageWikiLink Cicatrizant.
- Becaplermin wikiPageWikiLink Diabetes_mellitus.
- Becaplermin wikiPageWikiLink Foot_ulcer.
- Becaplermin wikiPageWikiLink Platelet-derived_growth_factor.
- Becaplermin wikiPageWikiLinkText "Becaplermin".
- Becaplermin wikiPageWikiLinkText "becaplermin".
- Becaplermin atcPrefix "A01".
- Becaplermin atcSuffix "AD08".
- Becaplermin atcSupplemental ",".
- Becaplermin casNumber "165101".
- Becaplermin chembl "1201556".
- Becaplermin chemspiderid "none".
- Becaplermin drugbank "DB00102".
- Becaplermin legalStatus "Rx only".
- Becaplermin medlineplus "a699049".
- Becaplermin pregnancyCategory "C".
- Becaplermin routesOfAdministration "Topical".
- Becaplermin tradename "Regranex".
- Becaplermin unii "1".
- Becaplermin verifiedfields "changed".
- Becaplermin verifiedrevid "458285090".
- Becaplermin wikiPageUsesTemplate Template:ATC.
- Becaplermin wikiPageUsesTemplate Template:Cascite.
- Becaplermin wikiPageUsesTemplate Template:Chemspidercite.
- Becaplermin wikiPageUsesTemplate Template:Dermatologic-drug-stub.
- Becaplermin wikiPageUsesTemplate Template:Drugbankcite.
- Becaplermin wikiPageUsesTemplate Template:Drugbox.
- Becaplermin wikiPageUsesTemplate Template:Drugs.com.
- Becaplermin wikiPageUsesTemplate Template:Ebicite.
- Becaplermin wikiPageUsesTemplate Template:Fdacite.
- Becaplermin wikiPageUsesTemplate Template:Gastrointestinal-drug-stub.
- Becaplermin wikiPageUsesTemplate Template:Growth_factors.
- Becaplermin wikiPageUsesTemplate Template:Preparations_for_treatment_of_wounds_and_ulcers.
- Becaplermin wikiPageUsesTemplate Template:Reflist.
- Becaplermin wikiPageUsesTemplate Template:Stomatological_preparations.
- Becaplermin subject Category:Dermatologic_drugs.
- Becaplermin hypernym Cicatrizant.
- Becaplermin type ChemicalSubstance.
- Becaplermin type Drug.
- Becaplermin type Chemical.
- Becaplermin type Drug.
- Becaplermin type Redirect.
- Becaplermin type ChemicalObject.
- Becaplermin type Thing.
- Becaplermin type Q8386.
- Becaplermin comment "Becaplermin (brand name Regranex) is a cicatrizant, available as a topical gel. Regranex is a human platelet-derived growth factor indicated along with good wound care for the treatment of lower extremity diabetic neuropathic ulcers. Use for diabetic foot ulcers has been described. Studies of becaplermin showed that when used with good wound care, complete healing significantly increased and the ulcers healed on average 6 weeks faster.".
- Becaplermin label "Becaplermin".
- Becaplermin sameAs Q2313188.
- Becaplermin sameAs Becaplermin.
- Becaplermin sameAs Bekaplermin.
- Becaplermin sameAs Becaplermina.
- Becaplermin sameAs m.02x30bf.
- Becaplermin sameAs Бекаплермин.
- Becaplermin sameAs Bekaplermin.
- Becaplermin sameAs Bekaplermin.
- Becaplermin sameAs Q2313188.
- Becaplermin wasDerivedFrom Becaplermin?oldid=691417139.
- Becaplermin isPrimaryTopicOf Becaplermin.